Evidence map›Paper›PMID 36777516›Full record

ArticleAmerican journal of cancer research2023

A novel PTEN mutant caused by polymorphism in cis-regulatory elements is involved in chemosensitivity in breast cancer.

Jing Wang, Shasha Zhang, Jiaxin Zhang, Zhongliang Zhang, Qinglong Ma, Wenkang Fu, Xiaohua Chen, Dapeng Zhao, Meie Zhao, Cuixia Di and 1 more

Abstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jing WangSchool of Basic Medical Sciences, Lanzhou University Lanzhou 730000, Gansu, China.
Shasha ZhangSchool of Basic Medical Sciences, Lanzhou University Lanzhou 730000, Gansu, China.
Jiaxin ZhangSchool of Biological and Pharmaceutical Engineering, Lanzhou Jiaotong University Lanzhou 730070, Gansu, China.
Zhongliang ZhangOncology Department, The First People's Hospital of Lanzhou City Lanzhou 730000, Gansu, China.
Qinglong MaSchool of Basic Medical Sciences, Lanzhou University Lanzhou 730000, Gansu, China.
Wenkang FuThe First Clinical Medical School of Lanzhou University Lanzhou 730000, Gansu, China.
Xiaohua ChenBio-Medical Research Center, Institute of Modern Physics, Chinese Academy of Sciences Lanzhou 730000, Gansu, China.
Dapeng ZhaoBio-Medical Research Center, Institute of Modern Physics, Chinese Academy of Sciences Lanzhou 730000, Gansu, China.
Meie ZhaoSchool of Basic Medical Sciences, Lanzhou University Lanzhou 730000, Gansu, China.
Cuixia DiBio-Medical Research Center, Institute of Modern Physics, Chinese Academy of Sciences Lanzhou 730000, Gansu, China.
Xiaodong XieSchool of Basic Medical Sciences, Lanzhou University Lanzhou 730000, Gansu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphatase and tensin homolog (

Indexed as

alternative splicingbreast cancerchemosensitivityPTENsingle nucleotide polymorphism

Identifiers

PMID36777516
PMCPMC9906080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.